PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

acamprosate vs memantine

Side-by-side comparison of acamprosate and memantine Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
acamprosate GABA Analog (Alcohol Dependence)
memantine NMDA Receptor Antagonist
Type
acamprosate Prescription
memantine Prescription
Summary
acamprosate

Acamprosate is a medicine that can help you stay away from alcohol if you are alcohol-dependent and have already stopped drinking. It should be used with counseling and support.

memantine

Memantine is a medicine used to treat moderate to severe Alzheimer's disease. It may help with memory and thinking.

What It Treats
acamprosate

Acamprosate helps people who are alcohol-dependent to not drink alcohol. You must have already stopped drinking before you start taking acamprosate. This medicine works best when it is part of a complete treatment plan that includes counseling and support.

memantine

Memantine is used to treat moderate to severe Alzheimer's disease. Alzheimer's is a brain disease that slowly gets worse over time. Memantine may help improve memory, awareness, and the ability to perform daily tasks.

How It Works
acamprosate

Acamprosate is similar to a natural substance in your brain. It is thought to work by helping to restore the normal balance of brain activity that is changed by long-term alcohol use. This can reduce your craving for alcohol.

memantine

Memantine is an NMDA receptor antagonist. This means it blocks the effects of a chemical in the brain called glutamate. By blocking glutamate, memantine may help protect brain cells from damage.

Common Side Effects
acamprosate
  • Accidental injury
  • Weakness
  • Pain
  • Loss of appetite
  • Diarrhea
memantine
  • Dizziness
  • Headache
  • Confusion
  • Constipation
FAERS Reports
acamprosate
  • Low blood pressure 14
  • Weakness 13
  • Condition worsened 13
  • Using the medicine for something it is not approved for 13
  • Sudden kidney damage 12
memantine
  • Falling 937
  • Death 853
  • The medicine did not work 811
  • Using the medicine for something it's not approved for 740
  • Confusion 707
Serious Warnings
acamprosate

Acamprosate may increase the risk of suicidal thoughts or actions. Your doctor should watch you for depression or suicidal thoughts. Tell your doctor right away if you have any new or worsening symptoms of depression or suicidal thoughts.

memantine

If you have conditions that make your urine less acidic (more alkaline), memantine levels in your blood may increase. This could increase the risk of side effects. Talk to your doctor if you have kidney problems or take medicines that affect urine pH.

Pregnancy
acamprosate

Acamprosate may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acamprosate passes into breast milk. Talk to your doctor if you are breastfeeding.

memantine

It is not known if memantine can harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if memantine passes into breast milk, so talk to your doctor if you are breastfeeding.

How to Read This acamprosate vs memantine Comparison

acamprosate is classified in the GABA Analog (Alcohol Dependence) drug class, while memantine sits within the NMDA Receptor Antagonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acamprosate has 65 submissions while memantine has 4,048. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acamprosate and memantine — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.